Prasco announced that it has entered into an agreement with Shire to distribute Carbamazepine extended-release capsules, the authorized, AB-rated, generic version of Shire’s Carbatrol capsules. Carbamazepine extended-release capsules will be made available by Prasco in 100mg, 200mg, and 300mg dosage strengths.

Carbamazepine extended-release capsules, a dibenzazepine, are indicated for the treatment of nerve pain, including trigeminal or glossopharyngeal neuralgia, as well as the treatment of generalized tonic-clonic, partial, or mixed seizures.

For more information visit